References
- Niederkorn J. Y., Meunier P. C. Spontaneous immune rejection of intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci. 1985; 26: 877–884
- Knisely T. L., Luckenbach M. W., Fischer B. J., Niederkorn J. Y. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors. J. Immunol. 1987; 138: 4515–4523
- Khodadoust A. A., Roozitalab H. M., Smith R. E., Green W. R. Spontaneous regression of retinoblastoma. Surv. Ophthalmol. 1977; 21: 467–478
- Sanborn G. E., Augsburger J. J., Shields J. A. Spontaneous regression of bilateral retinoblastoma. Br. J. Ophthalmol. 1982; 66: 685–690
- Reese A. B. Retinoblastoma and other neuroectodermal tumors of the retina. “Tumors of the Eye,”, A. B. Reese. Harper and Row, New York 1963; 89–123
- Uyttenhove C., van Snick J., Boon T. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815 I. Rejection by syngeneic mice. J. Exp. Med. 1980; 152: 1175–1183
- Boon T., van Snick J., van Pel A., Uyttenhove C., Marchand M. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815 II. T lymphocyte-mediated cytolysis. J. Exp. Med. 1980; 152: 1184–1193
- Niederkorn J. Y., Streilein J. W. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses. J. Immunol. 1983; 131: 2670–2674
- Ortaldo J. R., Mason L. H., Mathieson B. J., Liang S. M., Flick D. A., Herberman R. B. Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature 1986; 321: 700–702
- Niederkorn J. Y., Streilein J. W. Adoptive transfer of immunity to intraocular tumors in mice. Invest. Ophthalmol. Vis. Sci. 1984; 25: 336–342
- Hsu S. -M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immuno-peroxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577–580
- Erickson R. P., Tachibana O. K., Herzenberg L. A., Rosenberg L. T. A single gene controlling hemolytic complement and a serum antigen in the mouse. J. Immunol. 1964; 92: 611–615
- Old L. J. Tumor necrosis factor (TNF). Science 1985; 230: 630–632
- Burnet F. M. the concept of immunologic surveillance. Progr. Exp. Tumor Res. 1970; 13: 1–27
- Friedlaender M. H. Ocular Tumors. “Allergy and Immunology of the Eye,”. Harper and Row, Hagerstown, 308
- Gangwar D. N., Jain I. S., Gupta A., Sharma P. C. Bilateral spontaneous regression of retinoblastoma with dominant transmission. Annal. Ophthalmol. 1982; 14: 479–480
- Char D. H., Wood I. S., Huhta K., Rand N., Morita C. T., Howes E. L., Jr. Retinoblastoma: tissue culture lines and monoclonal antibody studies. Invest. Ophthalmol. Vis. Sci. 1984; 25: 30–40
- Stutman O., Paige C. J., Figarella E. F. Natural cytotoxic cells against solid tumors in mice I. Strain and age distribution and target cell susceptibility. J. Immunol. 1978; 121: 1819–1826
- Beutler B., Cerami A. Cachectin: More than a tumor necrosis factor. New Engl. J. Med. 1987; 316: 379–385
- Dvorak H. F., Mihm M. C., Jr, Dvorak A. M., Barnes B. A., Manseau E. J., Galli S. J. Rejection of first-set skin allografts in man. J. Exp. Med. 1979; 150: 322–337